Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.

Core Points - Novavax's updated COVID-19 vaccine (2024-2025 Formula) is now available at thousands of locations across the U.S. for individuals aged 12 and older [1][3] - The vaccine is the only protein-based option available this fall and has received Emergency Use Authorization (EUA) from the FDA on August 30, 2024 [3][5] - The vaccine targets the JN.1 variant and has shown cross-reactivity against other lineage viruses [4][12] Availability and Distribution - The updated vaccine is expected to be widely available through agreements with major pharmacy retailers including CVS, Walgreens, and Costco, among others [3][4] - The number of locations stocking the vaccine has more than doubled compared to the previous year, enhancing consumer access [4] Vaccine Composition and Technology - The Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2705) is formulated to target the JN.1 variant and utilizes Novavax's Matrix-M adjuvant to enhance the immune response [12][13] - The vaccine is presented in a pre-filled syringe for convenience and is stored at 2° to 8°C, allowing for the use of existing vaccine supply chains [4][12] Safety and Efficacy - The vaccine is indicated for active immunization against COVID-19 caused by SARS-CoV-2 in individuals aged 12 and older [7] - Contraindications include a known history of severe allergic reactions to any component of the vaccine [8] - Adverse reactions may include injection site pain, fatigue, and muscle pain, among others [11]